- Home
- KALU vs MDXG Comparison
KALU vs MDXG Comparison
Compare KALU & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALU
- MDXG
- Stock Information
- Founded
- KALU 1946
- MDXG 2006
- Country
- KALU United States
- MDXG United States
- Employees
- KALU N/A
- MDXG N/A
- Industry
- KALU Metal Fabrications
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- KALU Industrials
- MDXG Health Care
- Exchange
- KALU Nasdaq
- MDXG Nasdaq
- Market Cap
- KALU 1.1B
- MDXG 1.1B
- IPO Year
- KALU 1991
- MDXG N/A
- Fundamental
- Price
- KALU $73.68
- MDXG $9.12
- Analyst Decision
- KALU Buy
- MDXG Strong Buy
- Analyst Count
- KALU 3
- MDXG 5
- Target Price
- KALU $82.33
- MDXG $12.00
- AVG Volume (30 Days)
- KALU 98.5K
- MDXG 674.7K
- Earning Date
- KALU 02-19-2025
- MDXG 02-26-2025
- Dividend Yield
- KALU 4.18%
- MDXG N/A
- EPS Growth
- KALU 252.66
- MDXG N/A
- EPS
- KALU 2.90
- MDXG 0.52
- Revenue
- KALU $2,980,300,000.00
- MDXG $342,804,000.00
- Revenue This Year
- KALU N/A
- MDXG $9.56
- Revenue Next Year
- KALU $6.84
- MDXG $9.19
- P/E Ratio
- KALU $25.38
- MDXG $18.12
- Revenue Growth
- KALU N/A
- MDXG 10.93
- 52 Week Low
- KALU $60.05
- MDXG $5.47
- 52 Week High
- KALU $102.42
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- KALU 52.55
- MDXG 53.35
- Support Level
- KALU $68.02
- MDXG $8.50
- Resistance Level
- KALU $72.46
- MDXG $9.71
- Average True Range (ATR)
- KALU 1.99
- MDXG 0.30
- MACD
- KALU 0.75
- MDXG -0.04
- Stochastic Oscillator
- KALU 79.18
- MDXG 51.24
About KALU Kaiser Aluminum Corporation
Kaiser Aluminum Corp produces and sells semi-fabricated specialty aluminum products predominantly to industrial customers. Its products include fabricated aluminum mill products such as flat-rolled (plate, sheet, and coil), extruded (rod, bar, hollows, and shapes), drawn (rod, bar, pipe, tube and wire) and certain cast aluminum products. Geographically, the company generates majority of its revenue from United States.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.